| Literature DB >> 35886840 |
Annamaria Mancini1,2, Daniela Vitucci1,2, Giuseppe Labruna3, Stefania Orrù1,2, Pasqualina Buono1,2.
Abstract
Human skeletal muscle contains three different types of fibers, each with a different metabolism. Exercise differently contributes to differentiation and metabolism in human myoblast cells. The aims of the present study were to investigate the effects of different types of chronic training on the human LHCN-M2 myoblast cell bioenergetic profile during differentiation in real time and on the ROS overproduction consequent to H2O2 injury. We demonstrated that exercise differently affects the myoblast bioenergetics: aerobic exercise induced the most efficient glycolytic and oxidative capacity and proton leak reduction compared to untrained or anaerobic trained sera-treated cells. Similarly, ROS overproduction after H2O2 stress was lower in cells treated with differently trained sera compared to untrained sera, indicating a cytoprotective effect of training on the reduction of oxidative stress, and thus the promotion of longevity. In conclusion, for the first time, this study has provided knowledge regarding the modifications induced by different types of chronic training on human myoblast cell bioenergetics during the differentiation process in real time, and on ROS overproduction due to stress, with positive implications in terms of longevity.Entities:
Keywords: exercise; human myoblast LHCN-M2; longevity; metabolism; oxidative stress
Mesh:
Substances:
Year: 2022 PMID: 35886840 PMCID: PMC9320149 DOI: 10.3390/ijms23147491
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Clinical–biochemical characterization of enrolled volunteers.
| Sport | Age (y) | Height (m) | Weight (kg) | BMI (kg/m2) | IGF-1 * ng/mL | Glucose mg/dL | LDH U/L | Hemoglobin (Hb) g/dL |
| 18.5–24.9 kg/m2 | 116–358 ng/mL | 60–110 mg/dL | 227–450 U/L | 13–17.5 g/dL | ||||
| SO | 22.8 ± 1.9 | 1.8 ± 0.1 | 71.2 ± 6.4 | 23.0 ± 1.6 | 230.7 ± 117.6 | 87.8 ± 11.6 | 380.4 ± 36.5 | 16.2 ± 0.9 |
| VB | 24.3 ± 1.0 | 1.8 ± 0.0 | 72.3 ± 5.0 | 23.0 ± 1.3 | 241.0 ± 92.9 | 84.0 ± 18.7 | 372.5 ± 38.1 | 15.9 ± 0.6 |
| SW | 22.7 ± 3.9 | 1.7 ± 0.0 | 69.2 ± 4.9 | 22.9 ± 1.3 | 190.2 ± 50.2 | 80.2 ± 10.5 | 400.3 ± 21.9 | 13.9 ± 1.7 |
| BB | 25.7 ± 2.4 | 1.8 ± 0 | 73.3 ± 7.2 | 23.5 ± 1.3 | 227.0 ± 39.3 | 79.5 ± 14.9 | 431.5 ± 21.7 | 15.2 ± 0.8 |
| Total Cholesterol mg/dL | HDL Cholesterol mg/dL | Triglycerides mg/dL | AST U/L | ALT U/L | GGT U/L | Sideremia µg/dL | Hematocrit (Ht) % | |
| 100–200 mg/dL | >35 mg/dL | <150 mg/dL | 1–40 U/L | 1–40 U/L | 1–50 U/L | 53–167 μg/dL | 42.0–50.0% | |
| SO | 177.3 ± 37.5 | 48.4 ± 9.6 | 127.8 ± 57.1 | 29.6 ± 10.2 | 32.0 ± 1.0 | 35.8 ± 17.5 | 125.6 ± 31.0 | 48.9 ± 2.3 |
| VB | 143.0 ± 24.5 | 49.0 ± 3.7 | 128.0 ± 81.6 | 21.0 ± 2.4 | 28.7 ± 11.2 | 33.3 ± 15.4 | 90.0 ± 22.0 | 48.8 ± 1.6 |
| SW | 166.2 ± 4.1 | 55.5 ± 12.3 | 82.5 ± 46.3 | 22.7 ± 5.9 | 23.2 ± 11.6 | 30.2 ± 19.4 | 89.5 ± 44.5 | 43.0 ± 4.1 |
| BB | 184.7 ± 25.5 | 50.7 ± 17 | 87.7 ± 20.8 | 30.2 ± 6.6 | 31.2 ± 4.0 | 13.8 ± 2.9 | 126.7 ± 58.2 | 45.2 ± 2.9 |
* IGF-1 = 88 ng/mL in UN pool of human sera from untrained healthy subjects. Abbreviations: BMI: body mass index; IGF-1: insulin-like growth factor-1; LDH: lactate dehydrogenase; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gamma-glutamyltransferase; SO: soccer players; VB: volleyball players; SW: swimmers; BB: body builders. Data are expressed as mean ± SEM. Table modified from Vitucci et al. [26].
Figure 1Extracellular acidification rate (ECAR) measured in real time under basal condition and in response to glucose, oligomycin and 2-deoxy-D-glucose (2DG) in differently trained sera-treated LHCN-M2 cells. (A) Bioenergetic profiling of differently treated LHCN-M2 cells. (B) Glycolytic capacity measured after the addition of oligomycin. Data expressed as mean ± SEM of four independent experiments. Data comparison between groups were performed using the Student’s t-test. ††† p < 0.001 GM vs. all treated cells; ** p < 0.01 vs. UN; ## p < 0.01 vs. DM; $ p < 0.01 SW vs. BB.
Figure 2Oxygen consumption rate (OCR) measured in differently trained sera-treated LHCN-M2 cells in real time under basal conditions and in response to the following inhibitors: oligomycin, carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone (FCCP), antimycin A and rotenone (Ant + Rot). (A) Bioenergetic profile; SRC (spare respiratory capacity) in GM cultured cells is reported for explanatory purposes; (B) basal respiration (before addition of oligomycin); (C) ATP-linked respiration (calculated as the difference between basal and after oligomycin addition rate); (D) proton leak (calculated as difference between oligomycin and Ant + Rot rate); (E) maximal respiration (calculated as the difference between FCCP and Ant + Rot rate); and (F) spare respiratory capacity (calculated as the difference between maximal respiration and basal respiration). Data expressed as mean ± SEM of four independent experiments. Data comparison between groups was performed using the Student’s t-test. ††† p < 0.001 GM vs. all treated cells; *** p < 0.001; ** p < 0.01; * p < 0.05 vs. UN; ## p < 0.01 vs. SO + VB.
Figure 3Reactive oxygen species (ROS) measured by the 2′,7′-dichlorofluorescin diacetate (DCFDA) assay. Sera-treated LHCN-M2 cells were insulted with increased H2O2 concentrations: (A) 5 μmol/L, (B) 10 μmol/L. Data comparison between groups was performed using the Student’s t-test. Data expressed as mean ± SEM of three independent experiments. *** p < 0.001 or ** p < 0.01 vs. UN; ### p < 0.001 or ## p < 0.01 vs. DM.